FMT
INSY

First Mercantile Trust’s Insys Therapeutics, Inc. INSY Stock Holding History

First Mercantile Trust’s Portfolio INSY Stock Details INSY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-3,570
Closed -$57K – 944
2016
Q1 		$57K Buy
3,570
+400
+13% +$7.6K 0.01% 819
2015
Q4 		$91K Buy
3,170
+830
+35% +$23K 0.01% 831
2015
Q3 		$67K Buy
+2,340
New +$86.1K 0.01% 893
2015
Q2 		– Sell
-320
Closed -$9K – 1101
2015
Q1 		$9K Buy
+320
New +$8.46K ﹤0.01% 1064

Other funds holding INSY

SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FHAM
Folger Hill Asset Management New York $16.5M AUM 19.96% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GAM
Gotham Asset Management New York $32.7B AUM 27.65% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HP
HealthInvest Partners Stockholm, Sweden $310M AUM 37.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

First Mercantile Trust's INSY Position: Q2 2016 in Review

First Mercantile Trust sold out of Insys Therapeutics, Inc. (INSY) in Q2 2016, closing a stake of 3,570 shares — an estimated $57K sold.

First Mercantile Trust first reported a position in INSY in Q1 2015 and held it in 4 quarters. The position peaked at $91K in Q4 2015. 124 funds tracked by Wall St. Rank hold INSY as of Q2 2016.

  • First Mercantile Trust reported no remaining Insys Therapeutics, Inc. position as of Q2 2016 after selling out during the quarter.
  • First Mercantile Trust sold 3,570 Insys Therapeutics, Inc. shares in Q2 2016, an estimated $57K.
  • First Mercantile Trust first reported a position in Insys Therapeutics, Inc. in Q1 2015 and held it in 4 quarters.
  • First Mercantile Trust's Insys Therapeutics, Inc. position peaked at $91K in Q4 2015.
  • 124 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q2 2016.

Based on First Mercantile Trust's 13F filing for Q2 2016, filed 10 Aug 2016.